Incyte Corporation vs Public Storage — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Public Storage trades at $310.72 (market cap $55.40B). The key difference: Public Storage is far larger — about 2.4× Incyte Corporation's market cap, and Public Storage pays a 3.8% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | PSA | |
|---|---|---|
Market Cap | $23.11B | $55.40B |
Sector | Health | Real Estate |
52-Week High | $118.52 | $329.64 |
52-Week Low | $67.38 | $258.44 |
Enterprise Value | $19.13B | $69.65B |
Dividend Yield | — | 3.8% |
Trailing returns across standard periods
Latest headlines on both assets
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →